Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.

about

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.

Item

http://www.wikidata.org/entity/Q48002231

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.

@en

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.

@nl

type

Item

label

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.

@en

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.

@nl

prefLabel

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.

@en

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.

@nl

P1476

Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate

@en

P2093

Audrey Le Gouëllec

http://www.w3.org/2001/XMLSchema#string

Bernard Priem

http://www.w3.org/2001/XMLSchema#string

Emeline Richard

http://www.w3.org/2001/XMLSchema#string

Eric Samain

http://www.w3.org/2001/XMLSchema#string

Olivier Renaudet

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of Sialyl-Tn in Cancer

Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity

Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.

A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.

An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions.

A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis.

Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.

Site-specific modification of recombinant proteins: a novel platform for modifying glycoproteins expressed in E. coli.

Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes.

Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine.

P304

1730-1734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CBIC.201700240

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sébastien Fort

Carlo Pifferi

Michele Fiore

P577

2017-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28632300

http://www.w3.org/2001/XMLSchema#string

P921

N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine